优化索引内镜后食管吞咽困难的管理算法:成本效果与成本最小化分析
本研究建立决策分析模型,比较三种策略:食管测压、先行阻抗平面监测必要时再测压、以及非算法常规诊疗。结果显示,对非结构性/机械性吞咽困难的常规食管动力检测因节省成本而非健康获益更受青睐;商业保险方角度下,常规测压的可节省成本阈值为报销费用低于2415美元,筛查阻抗平面监测为低于1130美元;年龄超过65岁患者阈值更低;当贲门失弛缓症疑似指数低于6%时,患者和保险方更偏好先行筛查阻抗平面监测。
要点
- 非结构性/机械性吞咽困难常规食管动力检测较非算法常规诊疗节省成本。
- 商业保险方角度,常规测压节省成本的报销费用阈值为低于2415美元。
- 筛查阻抗平面监测节省成本的报销费用阈值为低于1130美元。
核心结论
- 与指南一致,对非结构性/机械性吞咽困难的评估,常规食管动力检测相比非算法常规诊疗似乎对患者和保险方节省成本。
- 检测选择应基于疑似指数指导。
研究设计与样本
- 决策分析模型,比较三种策略:食管测压、筛查阻抗平面监测后必要时行食管测压、非算法常规诊疗。
- 诊断测试准确性根据普通胃肠病学人群中食管动力障碍的预期发生率调整。
- 对非结构性/机械性吞咽困难所有患者常规检测与对高度怀疑贲门失弛缓症患者选择性检测进行比较建模。
- 成本结果基于国家商业和医疗保险数据集按年龄和性别分层定义,健康结果在贲门失弛缓症人群中建模,时间跨度为1年。
主要发现
- 食管动力检测优于非算法常规诊疗是由于成本节省而非健康获益。
- 对商业保险方,非结构性/机械性吞咽困难常规食管测压的报销费用低于2415美元时可节省成本。
- 筛查阻抗平面监测的报销费用低于1130美元时可节省成本。
- 年龄超过65岁患者实现成本节省的报销费用阈值更低,主要由于保险。
- 性别对成本效果无显著影响;当贲门失弛缓症疑似指数低于6%时,患者和保险方偏好常规筛查阻抗平面监测后行测压。
关键数值与推荐
- 常规食管测压节省成本的报销费用阈值为低于2415美元(商业保险方角度)。
- 筛查阻抗平面监测节省成本的报销费用阈值为低于1130美元(商业保险方角度)。
- 年龄超过65岁患者报销费用阈值更低以实现成本节省。
- 贲门失弛缓症疑似指数低于6%时,患者和保险方偏好常规筛查阻抗平面监测后行测压。
临床怎么用
- 对非结构性/机械性吞咽困难的评估,常规食管动力检测相比非算法常规诊疗似乎对患者和保险方节省成本。
- 检测选择应基于疑似指数指导。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Guidelines advise esophageal motility testing for dysphagia when structural disorders are ruled out, but cost concerns impede adoption. We evaluated cost-effective positioning of esophageal motility testing in the algorithm to evaluate esophageal dysphagia. METHODS: We developed a decision analytic model comparing 3 strategies: (i) esophageal manometry, (ii) screening impedance planimetry followed by esophageal manometry if needed, or (iii) nonalgorithmic usual care. Diagnostic test accuracy was adapted to expected rates of esophageal motility disorders in general gastroenterology populations. We modeled routine testing for all patients with nonstructural/mechanical dysphagia compared with selective testing with strong suspicion for achalasia. Cost outcomes were defined on national commercial and Medicare datasets stratified on age and sex. Health outcomes were modeled on populations with achalasia. The time horizon was 1 year. RESULTS: Motility testing was preferred over nonalgorithmic usual care due to cost savings rather than health gains. To commercial insurers, routine esophageal manometry for nonstructural/mechanical dysphagia would be cost-saving below a reimbursed cost of $2,415. Screening impedance planimetry would be cost saving below a reimbursed cost of $1,130. The limit for reimbursed costs would be lower for patients older than 65 years to achieve cost savings mainly due to insurance. Sex did not significantly influence cost-effectiveness. Patients and insurers preferred routine screening impedance planimetry before manometry when the index of suspicion for achalasia was below 6%. DISCUSSION: Aligning with practice guidelines, routine esophageal motility testing seems cost saving to patients and insurers compared with nonalgorithmic usual care to evaluate nonstructural/mechanical dysphagia. Choice of testing should be guided by index of suspicion.
引用
- Shah ED, Yadlapati R, Chan WW, et al. Optimizing the Management Algorithm for Esophageal Dysphagia After Index Endoscopy: Cost-Effectiveness and Cost-Minimization Analysis. Am J Gastroenterol. 2023. PMID: 37883488. doi:10.14309/ajg.0000000000002521
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。